The Effect of Semaglutide on Blood Pressure in Patients without Diabetes: A Systematic Review and Meta-Analysis

(1) Background: Recent advances in the pharmacological treatment of obesity with glucagon-like peptide-1 receptor agonists (GLP-1 RA) highlight the potential to target excess body weight to improve blood pressure (BP). This review aimed to determine the BP reduction in trials of semaglutide for weig...

Descripción completa

Detalles Bibliográficos
Autores principales: Kennedy, Cormac, Hayes, Peter, Salama, Sulafa, Hennessy, Martina, Fogacci, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917722/
https://www.ncbi.nlm.nih.gov/pubmed/36769420
http://dx.doi.org/10.3390/jcm12030772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9917722/
https://www.ncbi.nlm.nih.gov/pubmed/36769420
http://dx.doi.org/10.3390/jcm12030772

Ejemplares similares